Overview
REVA is a technology platform for non-intrusive blood testing (currently detecting haemoglobin) and vital signs screening. It is targeted for blood sample characterisation and screening. It uses photoplethysmography (PPG) and spectral (400nm to 1000nm) with signal conditioning which is processed by a deep learning algorithm – all captured by a portable handheld device.
REVA is a reagentless blood testing and vital signs analyser. It is a portable non-invasive haemoglobin meter with vital signs analyser. Current parameters are haemoglobin count and vital signs. Possible parameters include glucose, urea and creatinine.
Applications
Healthcare Providers, Medical Centres
Features
REVA comprises the following features
-
Blood Components and Vital Signs Analysis
REVA enables gathering and analysis of blood components and vital signs of a patient/user via built-in chemometrics analysis using a near infrared (NIR) and photoplethysmographic (PPG) platform. -
Rapid and Non-Invasive Single Point of Detection
The platform provides a rapid scanning, reagentless, non-invasive and real-time single point of detection. -
Spectral Processing Engine Analytics
A robust spectral processing engine analytics consists of chemometrics and deep learning for spectral which enhances intelligence. -
Mobile and Dashboard Results
A mobile app communicates with REVA to display results. A results dashboard is also available via desktop.
A Reagentless Blood Testing and Vital Signs Analyser
Technology Benefits
Mi-GraphASC comprises the following features:
-
Accessible SaaS Platform
The platform offers a low-cost pay-per-use model, making it accessible for users and extensive in applications. -
Highly Scalable Design
AINS is designed to be highly scalable, making it suitable for a wide range of applications and industries. -
Productivity Enhancement for NIR Analysis
AINS has been reported to increase productivity by 100* times, making it an efficient and cost-effective solution for NIR analysis.
